https://pipelinereview.com/Alnylam-Presents-Positive-Late-Breaking-Data-from-Ongoing-Phase-1-Study-of-ALN-AGT-an-Investigational-RNAi-Therapeutic-for-the-Treatment-of-Hypertension/